Shanghai Xuerong Biotechnology Co.,Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 1,357.92 million compared to CNY 956.82 million a year ago. Revenue was CNY 1,374.86 million compared to CNY 973.54 million a year ago.

Net income was CNY 41.14 million compared to net loss of CNY 100.81 million a year ago. Basic earnings per share from continuing operations was CNY 0.08 compared to basic loss per share from continuing operations of CNY 0.21 a year ago. Diluted earnings per share from continuing operations was CNY 0.08.